Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-18 Purchase | 2023-12-20 10:56 am | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 10,000 | $0.7525 | $7,525 | 1,823,236 (Direct) | View |
| 2023-12-13 Purchase | 2023-12-15 6:29 pm | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 20,520 | $0.70913 | $14,551 | 1,813,236 (Direct) | View |
| 2023-12-11 Purchase | 2023-12-12 7:30 pm | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 29,776 | $0.64736 | $19,276 | 1,792,716 (Direct) | View |
| 2023-12-07 Purchase | 2023-12-08 7:20 pm | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 51,203 | $0.59504 | $30,468 | 1,762,940 (Direct) | View |
| 2023-11-20 Purchase | 2023-11-22 5:51 pm | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 7,366 | $0.43713 | $3,220 | 1,711,737 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Exercise | 2024-04-02 6:32 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A CHIEF FINANCIAL OFFICER | 9,375 | $0 | 297,599 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 6:32 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A CHIEF FINANCIAL OFFICER | 3,345 | $0.7075 | 297,599 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-02 6:31 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. SEE REMARKS | 31,250 | $0 | 2,222,924 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 6:31 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. SEE REMARKS | 2,453 | $0.7075 | 2,222,924 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 4:09 pm | N/A 2034-03-21 | Forte Biosciences Inc. | FBRX | FINCK BARBARA K Director | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 4:08 pm | N/A 2034-03-21 | Forte Biosciences Inc. | FBRX | Riley Antony A CHIEF FINANCIAL OFFICER | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 4:07 pm | N/A 2034-03-21 | Forte Biosciences Inc. | FBRX | Wagner Paul A. SEE REMARKS | 1,100,000 | $0 | 1,100,000 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:04 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 3,073 | $0.8217 | 183,405 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:04 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 7,500 | $0 | 183,405 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:02 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 3,841 | $0.8217 | 300,944 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:02 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 9,375 | $0 | 300,944 (Direct) | View |
| 2024-01-01 Tax Withholding | 2024-01-03 4:01 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 4,109 | $0.8217 | 2,225,377 (Direct) | View |
| 2024-01-01 Exercise | 2024-01-03 4:01 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 31,250 | $0 | 2,225,377 (Direct) | View |
| 2023-10-01 Tax Withholding | 2023-10-03 4:29 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 2,593 | $0.662 | 186,478 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-03 4:29 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 7,500 | $0 | 186,478 (Direct) | View |
| 2023-10-01 Tax Withholding | 2023-10-03 4:27 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 3,241 | $0.662 | 304,785 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-03 4:27 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 9,375 | $0 | 304,785 (Direct) | View |
| 2023-10-01 Tax Withholding | 2023-10-03 4:26 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 2,453 | $0.662 | 2,110,621 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-03 4:26 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 31,250 | $0 | 2,110,621 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:55 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Brun Scott C. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:54 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Williams Donald Allen Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:53 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Kornfeld Steven Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:52 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | GRYSKA DAVID W Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:50 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | FINCK BARBARA K Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:49 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Eichenfield Lawrence Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-19 Option Award | 2023-09-20 5:48 pm | N/A 2033-09-19 | Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 6:03 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Kornfeld Steven Director | 99,009 | $1.01 | 99,009 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 6:02 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Williams Donald Allen Director | 59,405 | $1.01 | 59,405 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 6:00 pm | N/A N/A | Forte Biosciences Inc. | FBRX | GRYSKA DAVID W Director | 148,514 | $1.01 | 148,514 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 5:58 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 74,257 | $1.01 | 84,071 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 5:57 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 148,514 | $1.01 | 176,776 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-02 5:56 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 247,524 | $1.01 | 1,675,574 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 4:08 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 2,593 | $1.04 | 114,814 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:08 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 7,500 | $0 | 114,814 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 4:06 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 3,241 | $1.04 | 156,012 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:06 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 9,375 | $0 | 156,012 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 4:04 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 2,453 | $1.04 | 1,865,550 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:04 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 31,250 | $0 | 1,865,550 (Direct) | View |
| 2023-04-01 Exercise | 2023-04-04 8:19 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 31,250 | $0 | 1,868,003 (Direct) | View |
| 2023-04-01 Tax Withholding | 2023-04-04 8:19 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 11,046 | $1.01 | 1,868,003 (Direct) | View |
| 2023-04-01 Exercise | 2023-04-04 8:18 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 9,375 | $0 | 159,253 (Direct) | View |
| 2023-04-01 Tax Withholding | 2023-04-04 8:18 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 3,241 | $1.01 | 159,253 (Direct) | View |
| 2023-04-01 Exercise | 2023-04-04 8:17 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 7,500 | $0 | 117,407 (Direct) | View |
| 2023-04-01 Tax Withholding | 2023-04-04 8:17 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 2,593 | $1.01 | 117,407 (Direct) | View |
| 2023-03-23 Option Award | 2023-03-23 4:17 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-27 8:17 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-25 Option Award | 2023-02-27 8:15 pm | N/A N/A | Forte Biosciences Inc. | FBRX | Chen Hubert C See remarks | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-12 4:05 pm | N/A 2033-01-10 | Forte Biosciences Inc. | FBRX | GRYSKA DAVID W Director | 50,000 | $0 | 50,000 (Direct) | View |